US panel OKs Moderna COVID-19 vaccine for emergency authorization
By Matthew Perrone and Lauran Neergaard
The Associated Press
WASHINGTON A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation and quickly OK the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
Once emergency use authorization is granted, Moderna will begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
FDA advisers pave way for second COVID-19 vaccine s U.S. rollout Associated PressFILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel s review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis.
Updated 12/17/2020 4:17 PM
WASHINGTON A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
A U.S. government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the national vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation and quickly OK the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
Once emergency use authorization is granted, Moderna will begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
Dec 18, 2020
WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
The FDA’s green light for emergency use is expected quickly. Moderna would then begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
COVID-19 Vaccine
The vaccination campaign has already started earlier this week with the first vaccine, developed by Pfizer and German firm BioNTech, to get a go-signal.
Moderna s dose has shown similar strong effectiveness, with 94 percent protection against COVID-19 based on the company s ongoing study involving 30,000 people.
About all panelists supported making the vaccine available to curb the further spread of the pandemic. However, one-panel member abstained after seven hours of debate over technical details of the company s study and plans.
Dr. Hayley Gans of Stanford University Medical Center said that the evidence that has been studied in great detail on the vaccine highly outweighs any of the issues they have seen.